Boustead Securities Client ADOMANI First to IPO on NASDAQ Under the Jobs Act Regulation A+. Shares Up 92%.
June 19, 2017
Boustead Securities Client AngioSoma, Inc. Starts SOMA Nutraceuticals, Inc.’s Operations
April 27, 2017
HOUSTON, TEXAS – (Uptick Newswire, April 26, 2017) – AngioSoma, Inc., (OTC Pink: SOAN) recently filed its 10K for the period ending September 30, 2016 and its 10Q for the period ending December 31, 2016. AngioSoma, Inc.’s management would like to update its shareholders on recent progress within its 2017 business plan, including starting operations at its SOMA Nutraceuticals, Inc. subsidiary and retaining Boustead Securities LLC.